Matthew A Nix

7PUBLICATIONS
45CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)MechanobiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Chemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 05, 2020
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells.

Jaewoong Lee, Mark E Robinson, Ning Ma

|Oct 23, 2020
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.

Anum Glasgow, Jeff Glasgow, Daniel Limonta

|Jul 24, 2020
Signalling input from divergent pathways subverts B cell transformation.

Lai N Chan, Mark A Murakami, Mark E Robinson

Pageof 2